This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Orphanet Journal of Rare Diseases Open Access 07 May 2022
Orphanet Journal of Rare Diseases Open Access 08 July 2021
Body composition, adipokines, bone mineral density and bone remodeling markers in relation to IGF-1 levels in adults with Prader-Willi syndrome
International Journal of Pediatric Endocrinology Open Access 16 January 2018
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Barsh, G.S., Farooqi, I.S. & O'Rahilly, S. Genetics of body-weight regulation. Nature 404, 644–651 (2000).
Clement, K. et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398–401 (1998).
Vaisse, C. et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 106, 253–262 (2000).
Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656–660 (1999).
Tschop, M., Smiley, D.L. & Heiman, M.L. Ghrelin induces adiposity in rodents. Nature 407, 908–913 (2000).
Nakazato, M. et al. A role for ghrelin in the central regulation of feeding. Nature 409, 194–198 (2001).
Inui, A. Ghrelin: An orexigenic and somatotrophic signal from the stomach. Nature Rev. Neurosci. 2, 551–560 (2001).
Cummings, D.E. et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714–1719 (2001).
Cummings, D.E. et al. Human plasma ghrelin levels after diet-induced weight loss and gastric bypass surgery. New Engl. J. Med. 346, 1623–1630 (2002).
Wren, A.M. et al. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86, 5992–5995 (2001).
Burman, P., Ritzen, E.M. & Lindgren, A.C. Endocrine dysfunction in Prader-Willi syndrome: A review with special reference to GH. Endocr. Rev. 22, 787–799 (2001).
Nicholls, R.D. & Knepper, J.L. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet. 2, 153–175 (2001).
Dubern, B. et al. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and α-melanocyte-stimulating hormone genes in severely obese children. J. Pediatr. 139, 204–209 (2001).
Janssen, J.A. et al. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur J Endocrinol 145, 711–716 (2001).
Asakawa, A. et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120, 337–345 (2001).
Weigle, D.S. et al. Effect of regional fat distribution and Prader-Willi syndrome on plasma leptin levels. J. Clin. Endocrinol. Metab. 82, 566–570 (1997).
Wren, A.M. et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50, 2540–2547 (2001).
Rittmaster, R.S., Loriaux, D.L. & Merriam, G.R. Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH: Evidence for somatotroph desensitization independent of GH pool depletion. Neuroendocrinology 45, 118–122 (1987).
About this article
Cite this article
Cummings, D., Clement, K., Purnell, J. et al. Elevated plasma ghrelin levels in Prader–Willi syndrome. Nat Med 8, 643–644 (2002). https://doi.org/10.1038/nm0702-643
This article is cited by
Orphanet Journal of Rare Diseases (2022)
Orphanet Journal of Rare Diseases (2021)
International Journal of Obesity (2021)
Reviews in Endocrine and Metabolic Disorders (2020)
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2019)